Unstable Core Training in Air Pistol Athletes Read more about Unstable Core Training in Air Pistol Athletes
Compassionate Use for BIA 28-6156 in Patients With Parkinson's Disease (PD) Who Have a Pathogenic Variant in the GBA1 Gene (GBA-PD) and Completed the ACTIVATE Study Read more about Compassionate Use for BIA 28-6156 in Patients With Parkinson's Disease (PD) Who Have a Pathogenic Variant in the GBA1 Gene (GBA-PD) and Completed the ACTIVATE Study
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M) Read more about A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Impact of Transcatheter Aortic Valve Implantation and Mitral Valve Repair on Sleep-Disordered Breathing Read more about Impact of Transcatheter Aortic Valve Implantation and Mitral Valve Repair on Sleep-Disordered Breathing
PA-001 Ph.1 Study in Healthy and Elderly Subjects Read more about PA-001 Ph.1 Study in Healthy and Elderly Subjects
Stanford University - Center for Definitive and Curative Medicine By jpalfreyman on Thu, 04/09/2026 - 15:16 Read more about Stanford University - Center for Definitive and Curative Medicine
Chlorhexidine and Zinc in Non-Surgical Periodontal Therapy Read more about Chlorhexidine and Zinc in Non-Surgical Periodontal Therapy
Noseguard for Prevention of Respiratory Infections in Real-World Use Read more about Noseguard for Prevention of Respiratory Infections in Real-World Use
Expanded Access to Vodobatinib for Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Have Not Responded to Previous Treatments Read more about Expanded Access to Vodobatinib for Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Have Not Responded to Previous Treatments
Context Therapeutics Inc. By jpalfreyman on Mon, 04/06/2026 - 15:36 Read more about Context Therapeutics Inc.
